PepGen Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
James McArthur
Chief executive officer
US$3.4m
Total compensation
CEO salary percentage | 16.7% |
CEO tenure | 4yrs |
CEO ownership | 0.005% |
Management average tenure | less than a year |
Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Here's Why We're Watching PepGen's (NASDAQ:PEPG) Cash Burn Situation
Nov 19PepGen (NASDAQ:PEPG) Is In A Good Position To Deliver On Growth Plans
Aug 06PepGen: EDOs Could Enhance Dystrophin Expression Beyond Scope Of Current Treatments
Jul 31The Prognosis For PepGen
May 20PepGen: Long Road Ahead
Jan 20Will PepGen (NASDAQ:PEPG) Spend Its Cash Wisely?
Nov 13Will PepGen (NASDAQ:PEPG) Spend Its Cash Wisely?
Jul 31We Think PepGen (NASDAQ:PEPG) Can Afford To Drive Business Growth
Dec 31Here's Why We're Not Too Worried About PepGen's (NASDAQ:PEPG) Cash Burn Situation
Sep 07PepGen GAAP EPS of -$1.23 misses by $0.47
Aug 12CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$87m |
Jun 30 2024 | n/a | n/a | -US$89m |
Mar 31 2024 | n/a | n/a | -US$80m |
Dec 31 2023 | US$3m | US$572k | -US$79m |
Sep 30 2023 | n/a | n/a | -US$74m |
Jun 30 2023 | n/a | n/a | -US$69m |
Mar 31 2023 | n/a | n/a | -US$67m |
Dec 31 2022 | US$5m | US$523k | -US$69m |
Sep 30 2022 | n/a | n/a | -US$61m |
Jun 30 2022 | n/a | n/a | -US$51m |
Mar 31 2022 | n/a | n/a | -US$39m |
Dec 31 2021 | US$4m | US$408k | -US$27m |
Compensation vs Market: James's total compensation ($USD3.43M) is above average for companies of similar size in the US market ($USD641.95K).
Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.
CEO
James McArthur (62 yo)
4yrs
Tenure
US$3,425,703
Compensation
Dr. James G. McArthur, Ph D., serves as the President, Chief Executive Officer, Treasurer and Secretary of PepGen Inc. since January 21, 2021. He joined PepGen Inc. in January 2021.He serves as the Presid...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4yrs | US$3.43m | 0.0052% $ 5.9k | |
Chief Financial Officer | 3.3yrs | US$1.97m | 0% $ 0 | |
Chief Medical Officer | 2.8yrs | US$1.41m | no data | |
Founder & Scientific Advisory Board Member | no data | no data | no data | |
Senior VP of IR & Corporate Communications | less than a year | no data | no data | |
General Counsel & Secretary | less than a year | no data | no data | |
Senior Vice President of Biological Chemistry | 3.8yrs | US$1.32m | no data | |
Chief of Staff | less than a year | no data | no data | |
Senior Vice President of Global Regulatory Affairs | less than a year | no data | no data | |
Senior VP of Portfolio and Program Management | less than a year | no data | no data | |
Senior Vice President of Clinical Development | less than a year | no data | no data | |
VP of Finance & Controller | 3yrs | no data | no data |
1.0yrs
Average Tenure
54yo
Average Age
Experienced Management: PEPG's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4yrs | US$3.43m | 0.0052% $ 5.9k | |
Founder & Scientific Advisory Board Member | no data | no data | no data | |
Independent Chair of the Board | 3.1yrs | US$154.82k | 0.013% $ 14.5k | |
Scientific Advisory Board Member | no data | no data | no data | |
Independent Director | 3.5yrs | US$123.32k | 0% $ 0 | |
Independent Director | 4.2yrs | US$111.32k | 0% $ 0 | |
Scientific Advisory Board Member | no data | US$85.25k | no data | |
Scientific Advisory Board Member | no data | no data | no data | |
Scientific Advisory Board Member | 3.3yrs | no data | no data | |
Scientific Advisory Board Member | no data | no data | no data | |
Scientific Advisory Board Member | no data | no data | no data | |
Scientific Advisory Board Member | no data | no data | no data |
3.5yrs
Average Tenure
62yo
Average Age
Experienced Board: PEPG's board of directors are considered experienced (3.5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 03:15 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PepGen Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Tazeen Ahmad | BofA Global Research |
Andrew Fein | H.C. Wainwright & Co. |
Joseph Schwartz | Leerink Partners LLC |